drugset / Trial / NCT00038922
Study Evaluating rhIL-11 in Left-Sided Ulcerative Colitis
Treatment
Summary
To explore the safety of orally delivered rhIL-11 in patients with mild to moderate left-sided ulcerative colitis. To explore the effects of orally administered rhIL-11 on pharmacogenomics in blood samples and in colonic biopsy tissue samples.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rhIL-11 | Protein / enzyme biologic | — | Oral |